Certified by Founder Lodge
Logos Capital
United States - Miami, Florida
INVESTOR
1 Disclosed Funding Rounds $41,500,000
21 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Logos Capital* is a global merchant finance firm focused on catalyzing regenerative revolutions Ecopreneurship through Venture Capital, Private Equity with nextgen family offices and blockcha
| Company | Date | Round | Raised |
|---|---|---|---|
Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
Parse Biosciences |
February, 15 ,2022 | Series B | $41,500,000 |
Maze Therapeutics |
December, 04 ,2024 | Series D | $115,000,000 |
858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
Expedition Therapeutics |
October, 14 ,2025 | Series A | $16,000,000 |
Maze Therapeutics |
December, 04 ,2024 | Series D | $115,000,000 |
Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
Expedition Therapeutics |
October, 14 ,2025 | Series A | $16,000,000 |
Beacon Biosignals |
November, 14 ,2025 | Series B | $86,000,000 |
Beacon Biosignals |
November, 14 ,2025 | Series B | $86,000,000 |
Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
Diagonal Therapeutics |
January, 13 ,2026 | Series B | $125,000,000 |
Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
Maze Therapeutics |
December, 04 ,2024 | Series D | $115,000,000 |
Expedition Therapeutics |
October, 14 ,2025 | Series A | $16,000,000 |
Beacon Biosignals |
November, 14 ,2025 | Series B | $86,000,000 |
Diagonal Therapeutics |
January, 13 ,2026 | Series B | $125,000,000 |
Scorpion Therapeutics
Parse Biosciences
Maze Therapeutics
858 Therapeutics
Boundless Bio
Adcendo
Expedition Therapeutics
Septerna
Beacon Biosignals
Mirador Therapeutics
Diagonal Therapeutics
Galoy
Kroo Bank
Bloom Group S.A.
Hubble Money
Artoh
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)